tirzepatide summit AHA 24 Late-Breaking Discussion: SUMMIT: in Patients with HFpEF and Obesity tirzepatide hfpef trial Impact of

Tchang said these rules are strict, but some exceptions are made for ethnicities such as those of South or East Asian descent where a BMI of 25 can be used as they have a lower threshold for overweight or obesity

PLoS One 18 , e0288820 (2023)

Berberian will carefully evaluate whether you are a suitable candidate

In February 2026, Eli Lily and Company notified that the U.S

Understanding how tirzepatide affects blood work markers helps illustrate its glucose-lowering mechanism and why that mechanism is inherently safer for urinary health

Resources We Trust Mayo Clinic Health System: Weigh Benefits, Risks Carefully Before Taking Off-Label Medication Johns Hopkins School of Public Health: Overweight and Obesity in People With Type 1 Diabetes Nearly Same as General Population Yale Medicine: Why Your Cardiologist May Prescribe Semaglutide (Wegovy) T1D Exchange: Using GLP-1 Medications in Type 1 Diabetes The Harvard Gazette: Losing Fat Is Good, But Losing Muscle Isnt Fang M et al